General MedicationsINTRAVENOUSGeneric
TORSEMIDE
TORSEMIDE
Standard Dose
50MG/5ML (10MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview TORSEMIDE is listed in Drugs@FDA under application 090656 (ANDA).
Marketing status: Discontinued Active ingredient TORSEMIDE Form and strength SOLUTION;INTRAVENOUS - 50MG/5ML (10MG/ML) Sponsor AM REGENT Submission history Latest submission status date: 2010-04-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview TORSEMIDE is listed in Drugs@FDA under application 090656 (ANDA). Marketing status: Discontinued Active ingredient TORSEMIDE Form and strength SOLUTION;INTRAVENOUS - 50MG/5ML (10MG/ML) Sponsor AM REGENT Submission history Latest submission status date: 2010-04-21 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.